England, Pamela Michael
- University of California, San Francisco · Pharmacology (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #13,877
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Pharmacology
NIH Funding · FY2022
Linked Award Amount
$757K
Full award amounts, FY2022
Award Records
2
Records listing this PI
Award-Linked Rank
#13,877
By linked amount among FY2022 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing England, Pamela Michael as a PI. Multi-PI records show the full award amount for context.
- 3R01NS108404-04S1R01Contact PIInvestigating the effect of Nurr1 ligands in Alzheimer's Disease modelsUniversity of California, San Francisco · Pharmacology (NIH department code)$403.8Kaward amount
- 5R01NS108404-05R01Contact PISelective modulators for the nuclear receptor Nurr1University of California, San Francisco · Pharmacology (NIH department code)$353.3Kaward amount
Award organization
Organizations that administered FY2022 awards listing England, Pamela Michael as a PI.
FY2022 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of California, San Francisco
- 2018$500K Cumulative Funding
- 2018R01 Grant Holder
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding